Credit: Shutterstock photoAmerican depository receipts of European stocks were 0.04% lower at 140.81 on the Bank of New York Mellon Europe ADR Index on Thursday morning.
Decliners in Continental Europe were led by Criteo ( CRTO ), a French technology company, 24.9% lower, followed by biopharmaceutical company TiGenix ( TIG ), down by 9.7% and Trivago ( TRVG ), an online travel booking website, 1.5% lower and telecommunications company Telecom Italia - Savings (TI.A), down by 1.2%.
In the UK, Akari Therapeutics ( AKTX ), a development-stage biopharmaceutical company, was 4.5% lower, followed by NuCana ( NCNA ), a clinical-stage biopharmaceutical company, down by 2% and British American Tobacco (BTI), 1.3% lower. Low-cost airline Ryanair (RYAAY) was down by 1.2%.
Gainers in Continental Europe were led by pharmaceutical company argenx (ARGX), up by 22.4%, followed by Cellectis (CLLS), a French genome engineering company, 5.6% higher and Edap (EDAP), a French medical devices developer, up by 3.1%. Forward Pharma (FWP) was 2.8% higher.
And, in the UK, GW Pharmaceuticals (GWPH) was 4% higher, Verona Pharma (VRNA) was up by 3.3% and Prudential (PUK), a financial services group, was 1.9% higher. Pharmaceutical company Nightstar (NITE) was up by 1.7%.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
Copyright (C) 2016 MTNewswires.com. All rights reserved. Unauthorized reproduction is strictly prohibited.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
